If there is any fatality, we will hold the state responsible, says SC
Delta plus variant leads to increased transmissibility, stronger binding to receptors of lung cells, potential reduction in monoclonal antibody response, says INSACOG, a consortium of 28 laboratories
An expert panel of the country's central drugs authority has reviewed and accepted the phase-3 trial data of Bharat Biotech's COVID-19 vaccine Covaxin, sources said on Tuesday.
Today's coronavirus numbers: Bengaluru (1,034 cases), Mumbai (521 cases), Chennai (439 cases), Kolkata (171 cases), Delhi (89 cases). Stay tuned for corona-related news
The Pfizer CEO said that a significant local manufacturing of vaccines that is happening at the Serum Institute of India will provide the backbone of vaccinating the Indian people.
The positivity rate was at 0.20 percent
Over 87 thousand samples were tested on Tuesday.
Eleven people who received the AstraZeneca-Oxford COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome
The state's death toll rose to 12,295
Brijesh Goyal, chairman of the Chamber of Trade and Industry, said traders can only ensure compliance of Covid norms inside their shops, godowns or offices.
Antibody cocktail is a combination of two drugs and its vial costs nearly Rs 60,000 in the market.
However, air-conditioned shopping complexes and malls will continue to remain shut.
Hope very soon we will finalise an agreement with the govt, says CEO Albert Bourla
Govt says MP, Karnataka, UP, Bihar, Haryana, Gujarat, Rajasthan, TN, Maharashtra, Assam 10 top performing states
Called Tapestry, the new testing tool is developed by the startup launched by IIT-Bombay professor Manoj Gopalkrishnan.
The report marked five trends in work and meeting as India and the world gradually unlocks, with employees on the verge of returning to the office post-Covid.
128 out of 176 tribal districts are performing better than all India vaccination coverage
Covaxin has shown the efficacy from the trial conducted on 25,800 subjects, according to a news report
The doses will consist of Moderna, Pfizer and Johnson & Johnson Covid-19 vaccines.
Recovery in revenue and margins will nevertheless spur hospitals to resurrect capex, which had almost halved year-on-year last fiscal.